DecisionView Inc., a provider of software solutions to optimize clinical trial performance for life sciences companies, recently announced the availability of DV OnDemand. This suite of application hosting and managed services is designed for StudyOptimizer, the company’s flagship solution to optimize the clinical trial recruitment and enrollment process.

Those operating in the pharmaceutical space are under increased pressure to develop and bring new drugs to market quickly, while cutting costs throughout the drug development process, according to Steve Andrade, CEO of DecisionView.

As such, companies are taking a critical look across all clinical development business processes for opportunities to streamline and improve effectiveness in bringing new therapies to market.

With StudyOptimizer, these companies are able to reduce clinical study costs and improve clinical trial predictability and operational efficiency. StudyOptimizer offers predictive analytics, simulations and scenario modeling capabilities and DV OnDemand lowers the cost of supporting on-going operations as a critical element to overall clinical trial success. 

"Pharmaceutical and biotech companies worldwide are challenged to cost effectively support the increasingly complex demands of their internal departments and clinical operations users,” said Andrade in a company statement.

“We realized the growing need to offer multiple options in providing a seamless and convenient experience for our customers and their IT departments. DV OnDemand ensures that the software runs on a highly scalable, secure and available infrastructure effectively relieving the challenges associated with maintaining software applications on-premise.”

DecisionView has opted to better align itself in the industry through a strategic partnership with OpSource. This partnership ensures that its customers’ stringent security and availability requirements are met.

OpSource is known for its extensive experience supporting mission-critical business applications and provides secure, comprehensive services with an impressive performance based track record and innovative on-demand platform.  

"In today's economy, companies must find secure, efficient ways to achieve their goals; this is particularly true for companies in the clinical trials field where millions of dollars are spent before a single dollar is earned," said OpSource CEO Treb Ryan, in the company statement.

"DecisionView decided to meet its clients' needs by providing a seamless on-demand solution that offered a high degree of security and met all audit requirements, and realized that to do so would require partnering with an experienced, award-winning on-demand solutions provider. We are proud that DecisionView recognizes our experience in this field as well as our commitment to providing our partners with a high quality on-demand product.” 

Technology is playing an increasingly important role in the pharmaceutical industry as companies are seeking to implement technology throughout all processes, including clinical trials. Technologies allows for streamlined automation in the clinical development process and better decision making.  

Andrade noted that the use of predictive modeling is expected to increase in this space, not only as a solo capability, but as a solution that converges predictive analytics, automation and the visualization of that information to support insightful and mission critical decision making.

DecisionView has created a distinct position in the marketplace by applying predictive modeling and planning discipline to the patient recruitment and enrollment process. StudyOptimizer software enhances the user’s ability to develop and regional or global plan for patient recruitment, monitor the recruitment progress and troubleshoot and adjust the plan according to objectives.  

StudyOptimizer has been proven in this area as delivering business benefits such as faster cycle times, reductions in clinical recruitment costs and increases in productivity. In addition, DecisionView’s deployment time is much quicker than other e-clinical technologies, as it can be up and running within a customer’s environment in 90 days or less. In an industry where time and accuracy are essential, DecisionView delivers a strong value proposition.